臺灣人文及社會科學引文索引資料庫系統

:::

詳目顯示

回上一頁
第 1 筆 / 總合 1 筆   第一頁 上一頁 下一頁 最後一頁
/1頁
題名：臺灣藥品給付協議實施特性分析
書刊名：臺灣公共衛生雜誌
作者：高雅芝／董鈺琪
作者(外文)：Kao, Ya-chih／Tung, Yu-chi
出版日期：2022
卷期：41:4
頁次：頁383-396
主題關鍵詞：給付協議；藥物給付；Managed entry agreement；Drug reimbursement
原始連結：連回原系統網址new window
相關次數：
  • 被引用次數被引用次數:期刊(0) 博士論文(0) 專書(0) 專書論文(0)
  • 排除自我引用排除自我引用:0
  • 共同引用共同引用:0
  • 點閱點閱:1
期刊論文
1.Pauwels, K.、Huys, I.、Vogler, S.、Casteels, M.、Simoens, S.(2017)。Managed entry agreements for oncology drugs: lessons from the European experience to inform the future。Front Pharmacol，8。  new window
2.Ferrario, A.、Arāja, D.、Bochenek, T.(2017)。The implementation of managed entry agreements in Central and Eastern Europe: findings and implications。Pharmacoeconomics，35，1271-1285。  new window
3.Robinson, M. F.、Mihalopoulos, C.、Merlin, T.、Roughead, E.(2018)。Characteristics of managed entry agreements in Australia。Int J Technol Assess Health Care，34，46-55。  new window
4.Chen, G. T.、Chang, S. C.、Chang, C. J.(2018)。New drug reimbursement and pricing policy in Taiwan。Value in Health Regional Issues，15，127-132。  new window
5.Guarga, L.、Gasol, M.、Reyes, A.(2021)。Implementing risk-sharing arrangements for innovative medicines: the experience in Catalonia (Spain)。Value Health，25，803-809。  new window
6.Dabbous, M.、Chachoua, L.、Caban, A.、Toumi, M.(2020)。Managed entry agreements: policy analysis from the european perspective。Value Health，23，425-433。  new window
7.Buyukkaramikli, N. C.、Wigfield, P.、Hoang, M. T.(2021)。A MEA is a MEA is a MEA? Sequential decision making and the impact of different managed entry agreements at the manufacturer and payer level, using a case study for an oncology drug in England。Eur J Health Econ，22，51-73。  new window
8.Mundy, L.、Trowman, R.、Kearney, B.(2019)。Improving access to high-cost technologies in the Asia region。Int J Technol Assess Health Care，35，168-175。  new window
9.Ferrario, A.、Kanavos, P.(2015)。Dealing with uncertainty and high prices of new medicines: a comparative analysis of the use of managed entry agreements in Belgium, England, the Netherlands and Sweden。Soc Sci Med，124，39-47。  new window
10.Andersson, E.、Svensson, J.、Persson, U.、Lindgren, P.(2020)。Risk sharing in managed entry agreements - a review of the Swedish experience。Health Policy，124，404-410。  new window
11.Al-Omar, H. A.、Alghannam, H. H.、Aljuffali, I. A.(2021)。Exploring the status and views of managed entry agreements in Saudi Arabia: mixed-methods approach。Expert Rev Pharmacoecon Outcomes Res，21，837-845。  new window
12.Carlson, J. J.、Chen, S.、Garrison, L. P.(2017)。Performance-based risk-sharing arrangements: an updated international review。Pharmacoeconomics，35，1063-1072。  new window
13.Neyt, M.、Gerkens, S.、San Miguel, L.、Vinck, I.、Thiry, N.、Cleemput, I.(2020)。An evaluation of managed entry agreements in Belgium: a system with threats and (high) potential if properly applied。Health Policy，124，959-964。  new window
14.Rotar, A. M.、Preda, A.、Loblova, O.(2018)。Rationalizing the introduction and use of pharmaceutical products: the role of managed entry agreements in Central and Eastern European countries。Health Policy，122，230-236。  new window
15.Maskineh, C.、Nasser, S. C.(2018)。Managed entry agreements for Pharmaceutical products in Middle East and North African Countries: payer and manufacturer experience and outlook。Value Health Reg Issues，16，33-38。  new window
16.Huang, L. Y.、Gau, C. S.(2020)。Lessons learned from the reimbursement policy for immune checkpoint inhibitors and real-world data collection in Taiwan。Int J Technol Assess Health Care，37。  new window
研究報告
1.Wenzl, M.、Chapman, S.(2019)。Performance-Based Managed Entry Agreements for New Medicines in OECD Countries and EU Member States: How They Work and Possible Improvements Going Forward。OECD Publishing。  new window
圖書
1.WHO(2015)。Access to New Medicines in Europe: Technical Review of Policy Initiatives and Opportunities for Collaboration and Research。WHO。  new window
其他
1.Ferrario, A.，Kanavos, P.。Managed entry agreements for pharmaceuticals: the European experience，http://eprints.lse.ac.uk/50513/。  new window
 
 
 
 
第一頁 上一頁 下一頁 最後一頁 top
QR Code
QRCODE

臺灣人文及社會科學引文索引資料庫

目前上線人數：1340（臺灣：1295，外國：45） ／ 本年度總使用人次：2488187 ／ 訪客人次（自102年09月）：68298284
國家圖書館著作權聲明 Copyright © 2013 All rights reserved.
本館地址: 100201臺北市中山南路20號． 本館地圖及交通資訊．
總機：(02)23619132．最佳瀏覽解析度為1024x768以上